Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
20 News Items found
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
Q&A
Memorial Sloan Kettering surgeon Prasad Adusumilli
CAR T Cell Therapy Shows Promise for Treating Mesothelioma

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
Feature
Model of TGF-beta molecule
An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective

Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
Finding
Alex Kentsis in his lab
Research Uncovers the Genetic Causes of Aggressive Leukemia in Children

Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition

Take a look back at some of the year’s biggest news in cancer research.
Roundup
ASH meeting signage
Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting

Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
Finding
Leukemia cells
Findings from Two Patients Shed New Light on Drug Resistance in AML

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.
In the Clinic
Chemical biologist Gabriela Chiosis in a laboratory
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
In the Clinic
Jedd Wolchok and Charlotte Ariyan in the lab
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.